M

Marinus Pharmaceuticals

D

MRNS

USD

0.075

(4.918%)

Market Closed

7,924.00

حجم التداول

-2.03

الربح لكل سهم

-

العائد الربحي

-0.601504

P/E

88,134,460.80

حجم السوق

اليوم

4.9180%

1 اسبوع

14.286%

1 شهر

19.403%

6 اشهر

-82.796%

12 اشهر

-77.224%

بداية السنة

-85.294%

كل الوقت

0%

أصول ذات صلة

Title:
Marinus Pharmaceuticals

Sector:

Healthcare

Industry:

Biotechnology

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا